Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Genetic Testing in the Workplace: Costs and Benefits.

Authors
Boden-LI
Source
Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations 1991:401-415
Link
NIOSHTIC No.
00213963
Abstract
The increased interest in the relationship between genetic markers and the risk of illness may result in more widespread use of genetic testing in the future, raising concerns about the potential social benefits and costs of workplace genetic testing. Specifics discussed included the private benefits and public health impacts of genetic testing, benefits to employers of genetic testing, costs to employers of genetic testing, public versus private costs and benefits, and potential misallocation of genetic testing resources. Several illustrations were offered from data on different kinds of medical screening and monitoring which demonstrated the relationship between the frequency of testing and facility size. From the perspective of the workers exposed to hazardous substances, genetic testing offers the hope of reducing the risk of illness and thus, may be of substantial benefit. However, incentives to screen may be too great for firms with good employment characteristics and too small for firms with poor employment characteristics.
Keywords
NIOSH-Grant; Grants-other; Genotoxic-effects; Biological-monitoring; Worker-motivation; Safety-practices; Cytotoxic-effects; Genetic-factors; Medical-screening; Risk-factors; Occupational-exposure;
Contact
School of Public Health Boston University 80 East Concord Street Boston, MA 02118
Publication Date
19910101
Document Type
Book or book chapter;
Editors
Groopman-JD; Skipper-PL;
Funding Amount
48535.00
Funding Type
Grant;
Fiscal Year
1991
NTIS Accession No.
NTIS Price
ISBN No.
0849388007
Identifying No.
Grant-Number-R01-OH-02739
Priority Area
Other Occupational Concerns; Grants-other;
Source Name
Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations
State
FL; MA;
Performing Organization
Boston University, Boston, Massachusetts
TOP